Join COPD Clinical Trials in Oklahoma City, OK, and help improve outcomes for those with Chronic Obstructive Pulmonary Disease (COPD). Hightower is recruiting participants for a study evaluating a new triple therapy aimed at reducing cardiopulmonary risks in COPD patients. The trial compares this innovative treatment to standard dual therapy to identify better outcomes. Participation is free, and all study-related care is provided at no cost. Eligible individuals, aged 40-80, can contribute to this important research and potentially improve their quality of life while receiving expert care. Fill out the form to determine your eligibility.
